• Earlier, more aggressive therapy for Type 2 patients
• More customized therapy for Type 1 and Type 2
• Better technology and treatments
  • Insulin analogs
  • Drugs
  • Smart pumps
  • Improved blood glucose monitors
  • Better lancets
• FDA taking its time!
• Nutraceuticals making waves

- Notes from over a dozen diabetes and obesity conferences in 2003 including:

• January’s ADA Annual Postgraduate Sessions
• February’s La Jolla Glucose Monitoring meeting
• June’s American Diabetes Association
• August’s American Association of Diabetes Educators
• September’s International Diabetes Federation
• October’s National Association for Obesity
• October’s FDA Obesity Session
• November’s Diabetes Technology
• December’s ADA Novel Role of Gut Hormones
• December’s ACE/AACE Consensus Conference on Inpatient Management
• And others...

- Our selection of 100 critical peer-reviewed research articles of 2003

- Key conferences to watch for in 2004

- Diabetes Close Up “High Five” Awards – the Top Five new diabetes products of 2003

Who will benefit?

• Professionals in business development, strategic planning, or marketing in companies with interest in diabetes or obesity that want to broaden their understanding of what is happening across medical technology, pharmaceutical, and biotech landscapes
• Investors looking to better understand the current and future market landscapes in diabetes and obesity 

Ordering

Ordering is available online or by calling 415 241 9500. 

• Report format: Available electronically in PDF format. 
• Pricing: $495 
• Please enquire for small company discounts and corporate license fees
• Payment Options:
  • By check (Please contact info@closeconcerns.com for address) 
  • Major credit card (via Paypal) - please click on the button: